Sign in
4

Changes in Ownership

CYTOKINETICS INC Filed Acc 0001127602-24-003154

President & CEO sold 12,500 shares at $79.57 ($994,625)

  • President & CEO acquired 12,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Blum Robert I · President & CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-01-31 Exercise or conversion : show line 1 in the form 10b5-1 +12,500 $6.67 $83,375 454,297 D
2024-01-31 Sale : show line 2 in the form 10b5-1 −12,500 $79.57 $994,625 441,797 D
Open-market sales · 12,500 sh · avg $79.57 · $994,625

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-01-31 Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (Right to Buy) −12,500 130,994 D
Loading xslF345X05/form4.xml…